東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Sphingolipid metabolism and metaboli...

Jiang, Xian-Cheng.

FindBook

Google Book

Amazon

博客來

Sphingolipid metabolism and metabolic disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Sphingolipid metabolism and metabolic disease/ edited by Xian-Cheng Jiang.
其他作者:	Jiang, Xian-Cheng.
出版者:	Singapore :Springer Nature Singapore : : 2022.,
面頁冊數:	viii, 213 p. :ill., digital ;24 cm.
內容註:	Chapter 1: Sphingolipids and Cholesterol -- Chapter 2: Sphingolipids in adipose: kin or foe? -- Chapter 3: De novo sphingolipid biosynthesis in atherosclerosis -- Chapter 4: Serine Palmitoyltransferase Subunit 3 and Metabolic Diseases -- Chapter 5: Molecular mechanisms of sphingolipid transport on plasma lipoproteins -- Chapter 6: Sphingosine 1-phosphate metabolism and signaling -- Chapter 7: Sphingomyelin synthase family and phospholipase Cs -- Chapter 8: Sphingolipid metabolism and signaling in endothelial cell functions -- Chapter 9: Cholesterol metabolism in chronic kidney disease: physiology, pathologic mechanisms, and treatment -- Chapter 10: Sphingolipids and asthma -- Chaper 11: Manifold Roles of Ceramide Metabolism in Nonalcoholic Fatty Liver Disease and Liver Cancer -- Chapter 12: Drug development in the field of sphinogolipid metabolism -- Chapter 13: Rare diseases in glycosphingolipid metabolism.
Contained By:	Springer Nature eBook
標題:	Sphingolipidoses. -
電子資源:	https://doi.org/10.1007/978-981-19-0394-6
ISBN:	9789811903946

Sphingolipid metabolism and metabolic disease
Sphingolipid metabolism and metabolic disease[electronic resource] /edited by Xian-Cheng Jiang. - Singapore :Springer Nature Singapore :2022. - viii, 213 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v. 13722214-8019 ;. - Advances in experimental medicine and biology ;v. 1372..

Chapter 1: Sphingolipids and Cholesterol -- Chapter 2: Sphingolipids in adipose: kin or foe? -- Chapter 3: De novo sphingolipid biosynthesis in atherosclerosis -- Chapter 4: Serine Palmitoyltransferase Subunit 3 and Metabolic Diseases -- Chapter 5: Molecular mechanisms of sphingolipid transport on plasma lipoproteins -- Chapter 6: Sphingosine 1-phosphate metabolism and signaling -- Chapter 7: Sphingomyelin synthase family and phospholipase Cs -- Chapter 8: Sphingolipid metabolism and signaling in endothelial cell functions -- Chapter 9: Cholesterol metabolism in chronic kidney disease: physiology, pathologic mechanisms, and treatment -- Chapter 10: Sphingolipids and asthma -- Chaper 11: Manifold Roles of Ceramide Metabolism in Nonalcoholic Fatty Liver Disease and Liver Cancer -- Chapter 12: Drug development in the field of sphinogolipid metabolism -- Chapter 13: Rare diseases in glycosphingolipid metabolism.

This book provides an up-to-date review of the fundamentals of sphingolipid metabolism and its role in metabolic diseases. Focusing on the sphingolipid de novo synthesis pathway, the effect of sphingomyelin, ceramide, and sphingosine-1-phosphate, and linkage between sphingolipids and other lipids, such as cholesterol, it covers serine palmitoyltransferase, ceramide synthases, ceramidases, sphingosine kinases, and sphingomyelin synthases, and more. While highlighting how rare diseases related to abnormal glycosphingolipid metabolism, this publication introduces sphingolipid metabolism-related diseases, such as lung diseases and cancers, as well as sphingolipid circadian regulation. The book demonstrates advances and limitations of research on sphingolipid metabolism and its roles in metabolic diseases and other diseases. It offers graduate students and researchers a coherent overview of sphingolipids, as well as the limitations of current research in the field, and promotes further studies on metabolic diseases, as well as pharmaceutical research on drug discovery based on sphingolipid de novo synthase.

ISBN: 9789811903946

Standard No.: 10.1007/978-981-19-0394-6doiSubjects--Topical Terms:

3597332
Sphingolipidoses.

LC Class. No.: RC632.S67

Dewey Class. No.: 616.399

Sphingolipid metabolism and metabolic disease
LDR:03111nmm a2200337 a 4500 001 2299648
003 DE-He213
005 20220503153456.0
006 m d
007 cr nn 008maaau
008 230324s2022 si s 0 eng d
020 $a 9789811903946 $q (electronic bk.)
020 $a 9789811903939 $q (paper)
024 7 $a 10.1007/978-981-19-0394-6 $2 doi
035 $a 978-981-19-0394-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC632.S67
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 616.399 $2 23
090 $a RC632.S67 $b S753 2022
245 0 0 $a Sphingolipid metabolism and metabolic disease $h [electronic resource] / $c edited by Xian-Cheng Jiang.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a viii, 213 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 2214-8019 ; $v v. 1372
505 0 $a Chapter 1: Sphingolipids and Cholesterol -- Chapter 2: Sphingolipids in adipose: kin or foe? -- Chapter 3: De novo sphingolipid biosynthesis in atherosclerosis -- Chapter 4: Serine Palmitoyltransferase Subunit 3 and Metabolic Diseases -- Chapter 5: Molecular mechanisms of sphingolipid transport on plasma lipoproteins -- Chapter 6: Sphingosine 1-phosphate metabolism and signaling -- Chapter 7: Sphingomyelin synthase family and phospholipase Cs -- Chapter 8: Sphingolipid metabolism and signaling in endothelial cell functions -- Chapter 9: Cholesterol metabolism in chronic kidney disease: physiology, pathologic mechanisms, and treatment -- Chapter 10: Sphingolipids and asthma -- Chaper 11: Manifold Roles of Ceramide Metabolism in Nonalcoholic Fatty Liver Disease and Liver Cancer -- Chapter 12: Drug development in the field of sphinogolipid metabolism -- Chapter 13: Rare diseases in glycosphingolipid metabolism.
520 $a This book provides an up-to-date review of the fundamentals of sphingolipid metabolism and its role in metabolic diseases. Focusing on the sphingolipid de novo synthesis pathway, the effect of sphingomyelin, ceramide, and sphingosine-1-phosphate, and linkage between sphingolipids and other lipids, such as cholesterol, it covers serine palmitoyltransferase, ceramide synthases, ceramidases, sphingosine kinases, and sphingomyelin synthases, and more. While highlighting how rare diseases related to abnormal glycosphingolipid metabolism, this publication introduces sphingolipid metabolism-related diseases, such as lung diseases and cancers, as well as sphingolipid circadian regulation. The book demonstrates advances and limitations of research on sphingolipid metabolism and its roles in metabolic diseases and other diseases. It offers graduate students and researchers a coherent overview of sphingolipids, as well as the limitations of current research in the field, and promotes further studies on metabolic diseases, as well as pharmaceutical research on drug discovery based on sphingolipid de novo synthase.
650 0 $a Sphingolipidoses. $3 3597332
650 0 $a Sphingolipids $x Metabolism. $3 3597333
650 1 4 $a Biomedical Research. $3 851895
650 2 4 $a Diseases. $3 618693
650 2 4 $a Internal Medicine. $3 858559
700 1 $a Jiang, Xian-Cheng. $3 3460847
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Advances in experimental medicine and biology ; $v v. 1372. $3 3597331
856 4 0 $u https://doi.org/10.1007/978-981-19-0394-6
950 $a Biomedical and Life Sciences (SpringerNature-11642)